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A mouse myeloma tumor was used as a model system to
study the biochemical
steps involved in the incorporation
of
mannose
into glycoproteins.
This
tumor,
MOPC-46B,
synthesizes
a K-type
immunoglobulin
light chain (K-46)
which is a glycoprotein
with a single oligosaccharide
side
chain containing mannose as one of its constituent
sugars.
MOPC-46B
microsomal
preparations
contain
enzymes
which transfer mannose from the sugar nucleotide,
GDPmannose, to endogenous lipid and protein acceptors.
Formation of the mannolipid
proceeds by the reversible transfer of
mannose from GDP-mannose
to an endogenous phospholipid.
The mannolipid
was purified and characterized
by chemical
methods and mass spectrometry
as a mannosyl-monophosphoryl-dihydropolyisoprenol,
containing
at least 18 isoprene
units, one of which is saturated.
The mannolipid
was implicated
as an intermediate
in the
in vitro mannosylation
of endogenous
protein acceptors by
three kinds of experiments.
(a) Incorporation
of [l%]mannose into protein was observed after the initial substrate,
GDP-mannose,
had been destroyed
by sugar nucleotide
hydrolases
associated
with the microsomal
preparations.
The continued increase in radioactivity
in the protein fraction
occurred concomitantly
with a loss of radioactivity
from the
mannolipid
fraction.
(b) I ncorporation
of [14C]mannose into
both lipid and protein was inhibited
by EDTA added at zero
time.
However,
addition
of EDTA after mannolipid
synthesis had occurred
resulted
in cessation
of mannolipid
formation
but continued
incorporation
of mannose
into
protein to an extent proportional
to the amount of mannolipid
originally
formed.
The increase in radioactivity
in protein
was again accompanied
by a loss of radioactivity
from the
mannolipid.
(c) When microsomes
were pulsed briefly with
GDP-[14C]mannose,
which was then chased by a large excess
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of unlabeled
GDP-mannose,
incorporation
of [‘XZ]mannose
into lipid ceased immediately
with the chase, while incorporation into protein continued
afterwards
to an extent proportional to the amount of mannolipid
formed prior to the chase.
Evidence that the mannolipid
could function as a donor of
mannose residues to protein was obtained by demonstrating
that microsomes
catalyze the transfer of [*4C]mannose from
exogenously
supplied
mannolipid
to endogenous
protein
acceptors.
The amount of mannose transferred
to protein
was proportional
to both microsomal protein and lipid concentrations.
In addition,
the amount of mannose transferred
to protein from exogenous mannolipid
is comparable
to that
incorporated
from an equivalent
amount
of mannolipid
generated
endogenously
from GDP-mannose.
Gel filtration
profiles
of the [14C]mannose-containing
protein formed in this system are essentially identical regardless of whether
GDP-mannose
or mannolipid
is used as
substrate.
In both cases the radioactive protein fractionates
in a manner similar to authentic K-46 (mol wt 24,000).
The
mannose-containing
protein
formed
from
either
GDPmannose or mannolipid
was degraded sequentially
by Pronase and subtilisin.
The products
formed
from either
substrate appeared to be identical and exhibited
chromatographic and electrophoretic
characteristics
of glycopeptides.
It was concluded that mammalian
microsomal preparations
contain
an endogenous
phospholipid,
characterized
as a
dihydropolyisoprenol-monophosphate,
which
serves as an
acceptor of mannose from GDP-mannose,
resulting
in the
formation
of mannosyl-monophosphoryl-dihydropolyisoprenol, and that this mannolipid
serves as a glycosyl donor for
transfer
of mannose
residues
to endogenous
protein
acceptors.
The evidence indicates that the mannolipid
is an
essential intermediate
in the in vitro transfer
of mannose
from GDP-mannose
to protein.

The predominant
type of glycoprotein in plasma contains carbohydrate linked by an N-glycosyl bond between a reducing
terminal N-acetylglucosamine
in the oligosaccharide
and an asparagine

residue

has been divided

in the

polypeptide

structurally

chain.

into an internal

The

oligosaccharide

or “core,”

region
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1 The abbreviations
used are : K-46, the +immlmoglobldin
K-type light chain synthesized by the MOPCIBB
mouse myeloma
tumor; HAc, acetic acid; NH4Ac, ammonium acetate.

been detected in a number of mammalian
cell types, and they
have been implicated as intermediates in the transfer of mannose
from GDP-mannose
to glycoproteins,
in general (S), and to
secreted proteins, in particular
(17). However, direct characterization of the mannolipids
and conclusive identification
of trichloroacetic acid-insoluble
products as glycoproteins
have not
been previously reported.
In the present study we establish the
identity of the mannolipid
and the glycoprotein
nature of the
trichloroacetic
acid-insoluble
product, and demonstrate by indirect and direct methods that the mannolipid
is an intermediate
in the in vitro mannosylation of endogenous, microsomal protein.
EXPERIMENTAL

PROCEDURE

Materials
Plasma cell tumor, MOPC-4613, was obtained from Dr. Michael Potter, National Institutes of Health, and was maintained
by serial transplantation
in Balb/c mice. The tumors used were
generation numbers 71 to 92 and were used 3 to, 4 weeks after
subcutaneous transplantation.
GDP-[ U-V]mannose
(152 mCi
per mM) and [3H]GDP (2 Ci per InM) were obtained from New
England Nuclear Corp. Nonradioactive
sugars, nucleotides, and
their derivatives, and the enzymes Pronase, subtilisin, and alkaline phosphatase were obtained from Sigma.
Triton X-100
used in incubation
mixtures and all reagents for radioactivity
measurements were obtained from Packard Instruments.
The
DEAE-cellulose
used was Whatman DE-52 (H. Reeve Angel and
Co.). Sephadex G-50, G-150, LH-20, and LH-60 were obtained
from Pharmacia Fine Chemicals, Inc. Bio-Gel P-2 and Dowex
l-X8 were obtained from Bio-Rad.
Unisil activated silicic acid
was obtained from Clarkson Chemical Co., Inr.
Adsorbeilts for
thin layer chromatography
were purchased from E. 1Ierck.
Organic solvents used in purification of lipid were reagent grade,
freshly redistilled,
and contained 0.01 y0 butylated
hydrosytoluene as antioxidant.
Radioactivity

Xeasurenaents

Quantitative
determinations
of radioactivity
were obtained on
a Packard liquid scintillation
spectrometer, model 4322. Lipid
and aqueous samples were counted in a scintillation
fluid consisting of toluene:Triton
X-100 (2:l) containing 5.5 g per liter
of 2,5diphenyloxazole
and 125 mg per liter of 1 ,4-bis[2-(4.
methyl-5-phengloxazolyl)]benzene.
Particulate
pamplrs
were
solubilized in hydroxide of Hyamine 10X and counted in tolucne
containing 4.0 g per liter of 2,5~diphenyloxazolc
and 100 mg per
liter of 1,4-bis[2-(5-phcnylosazolyl)]benzene.
Analytical

Methods

Protein was determined by the method of Lo\\-ry et al. (18), as
modified by Miller (19), using bovine serum albumin as standard.
Lipid phosphate was determined according to l’artlett
(20), as
modified by Dittmer and Wells (al), and reducing sugar by the
m&hod of Park and Johnson (22).
Preparation

oj Xicrosomal

Fraction

Small tumors (2 to 3 g) were excised and washed with ice-cold
homogenizing
buffer (0.05 M Tris-maleate,
pH 7.4, containing
0.25 M sucrose). All subsequent procedures were carried out at
O-4”. Necrotic tissue was removed, and the tumor was minced
and susl)ended in 2>$ volumes of buffer. The suspension was
homogenized with 6 to 10 strokes of a motor-driven
glxs+Teflon
Potter-Elvehjcm
homogenizer.
The crude homogenate was centrifugcd at 10,000 X g for 10 min in a Sorvall KC-213 cclltrifuge
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containing mannose and N-acetylglucosamine
and an external
region containing
galactose, fucose, sialic acid, and additional
N-acetylglucosamine
residues (2, 3).
The biosynthesis of the external region proceeds by addition of
single sugar residues to a growing oligosaccharide
side chain.
The sequential addition of external N-acetylglucosamine,
galactose, sialic acid, and fucose residues by transferases of the endoplasmic reticulum and Golgi apparatus has been accomplished
using exogenous protein acceptors, generally prepared by treatment of native glycoproteins with the appropriate glycosidase(s)
(2-5).
Investigations
on the mode of addition of the mannose
residues in the core region, however, have been hampered by an
inability to prepare efficient exogenous acceptors by glycosidase
treatments, or to find native proteins which can function as artificial acceptors.
Therefore, it has become necessary to study
mamlosyltransferase
reactions using endogenous acceptors contained in the transferase preparations
(6-8).
These studies are
frequently complicated by the low levels of endogenous acceptors
in cells and their heterogeneity with respect to both the polypeptide chains and the nature of the oligosaccharide
side chains.
Some of these difficulties may be minimized in a system that
produces a single mannose-containing
glycoprotein
with one
oligosaccharide
side chain of defined structure.
We have therefore selected a mouse myeloma tumor, MOPC-46B,
as a model
system to study the addition of mannose residues to glycoproteins, and to investigate specifically the possible role of lipid intermediates in this process.
The plasma cell tumor, MOPC-4613, synthesizes a K type
irnmunoglobulin
light chain, which is a glycoprotein
(mol wt 24,000) with a single serum type oligosaccharide
side chain attached at asparagine residue 34 in the peptide chain (9-11).
The oligosaccharide
contains 4 mannose residues in addition to
3 N-acctylglucosamine,
4 galactose, 2 fucose, and 2 sialic acid
residues.
The synthesis of K-46l accounts for 35 to 4Ocj, of the
total protein synthesis by MOPC-461~ cells in suspension in vitro,
as measured by relative rates of incorporation
of [3H]leucine into
immunoprecipitable
and total trichloroacetic
acid-precipitable
protein (10, 12). In addition, similar studies using [l-3H]galactose and [l-3H]mannose
indicate that K-46 represents at least
50% of the total glycoprotein
synthesis by the myeloma tumor
(12). Thus, the MOPC-46B
tumor is highly directed for synthesis of a single species of glycoprotein coiitaining a single type
of oligosaccharide side chain.
The role of polyisoprenol
phosphates as glycosyl acceptors
which mediate the transfer of sugars from sugar nucleotides to
polysaccharides has been clearly established in prokaryotic
systems (13). The widespread occurrence of similar polyisoprenoid
lipids in eukaryotic systems has led to intensive investigation of
their role in the synthesis of polysaccharides in yeast and plant
systems, and of glgcoproteins in mammalian systems (14). The
demonstration
that mammalian
glycoproteins
are glycosylated
by membrane-associated
enzymes (2-5), that the acceptor glycoproteins are intimately
associated with the intracellular
membrane fractions (2-8, II), and that these membranes contain
polyisoprenol
phosphate (14-16) which can function in vitro as
glycosyl acceptors (8, 16) has stirnulated a number of investigations using various sugars (N-acetylglucosamine,
glucose, galactose, and rnannose) and lipids (dolichols and vitamins h and K)
in order to evaluate the possible role of glycolipids in the biosynthesis of glycoproteins
(14). ~~aniiose-acceptil~g
lipids have
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in the SS-34 rotor.
The supernatant
fluid was decanted, and
the microsomal fraction was sedimented by centrifugation
for 2
hours at 78,000 x g in the Beckman No. 30 rotor.
The crude
microsomal pellet was resuspended in homogenizing
buffer at a
protein concentration
of 20 to 40 mg per ml. Enzymatic
activity for transfer of mannose from GDP-mannose
to lipid was
stable to freezing for several months.
The activity for transfer
of mannose from GDP-mannose
to protein was unstable, and
preparations morethan 1 week old were not used for that purpose.
Assay Procedures
Incorporation

of Mannose

into Lipid

and Protein

Transfer of Xannose

from Lipid

to Protein

Organic Solvent Extraction of Microsomal Protein-Microsomal
pellets were resuspended by gentle homogenization
in 3 volumes
of HzO, and 2-ml aliquots were frozen in a thin shell, lyophilized,
and then extracted for 1 hour at 0” with 10 ml of I-butanol.
The
delipidated
protein was collected by centrifuging for 15 min at
10,000 x g, and residual butanol was removed from the pellet
by lyophilization.
The delipidated protein was then resuspended
in homogenizing buffer so that I ml corresponded to 2 g of original
tumor.
The enzymatic activity for transfer of mannose from
lipid to protein was stable for several weeks upon freezing at
-20”.
Partial Purijkzation of JZannolipid-[14C]l\lannose-labeled
lipid
was extracted from muuse liver microsomes with butanol-pyridinium a&ate,
deacylated as described below, and applied in
CHCl, solution to a small column of DEAE-cellulose
prepared in
99% CH,OH according to Rouser (23) and equilibrated
wit’h
CHCla.
The column was washed in succession with 2 volumes

Proteolytic

Digestion of Mannose-containing

Protein

The 14C-labeled protein products were dispersed by sonication
in 1 ml of 10 M urea per 20 to 30 mg of protein, and diluted with
1 volume of 0.05 M Tris-Cl, pH 7.8, containing
1.5 rnM CaCl2.
Pronase was added (1% of protein by weight) and digestion was
carried out at 30”. After 18 hours the mixture was heatrd for I
min at loo“, sonicated for 10 s, and a second portion of I’ronase
was added.
After an additional 18 hours, the mixture was again
heated and sonicated, then adjusted to 10 m&l EDTA, 1% mercaptoethanol.
Subtilisin (1% of protein by weight) was added,
and digestion was continued for an additional
24 hours at 30”.
At the end of this time solid sodium dodecyl sulfate was added
to a final concentration
of 2%. The proteolytic digest was chromatographed
on a column (1 x 40 cm) of Sephades G-150 in
1% sodium dodccyl sulfate, 1 y0 2-mercaptocthanol,
0.1 BI EDTA,
0.05 M sodium phosphate, pH 8.0. The low molecular weight
products of the proteolytic digestion were collected from the retention volume of the Sephadcx G-150 column, the sodium dodecyl sulfate was rernoved on a column of Dowcs l-X8 (chloride
form) according to Weber and Kutrr (25), and urea and salts
were rcrnovcd by chromatography
011 Hio-Gel 1’.2 in H20. Recovery of a radioactivity
from the Dow-es 1-X8 and 13io-Gel P-2
columns was greater than 957,, and essentially all of the radioactivity is recovered at the exclusion volume on the Isio-Gel P-2
column.
Purification

of Bovine Liver Xannolipid

Bovine liver (6.5 kg) was homogenized
in a JYaring IUendor
in 2;s volumes of homogenizing
medium, filtered through two
layers of cheesecloth, and centrifuged at 1,500 x g for 30 min
The
in a Scrvall GS-3 rotor to remove whole cells and debris.
supernatant
was decanted, adjusted to pI-I 4.9 with 1 42 acletic
acid, and recentrifuged
at 10,000 X g for 30 min. The pellet
was resuspended to 9 liters with homogenizing
medium containing 5 mM MgCl, and 5 mM MnCl,, and incubated in 1 to 2 liter
volumes with 4 pM GDl’-[14C]mannose
(1 PC1 per PL~\I)for I5 min
at room temperature
and quenched by addition of 1 volume of
butanol-pyridinium
acetate.
The organic phase was separated
by ccntrifugation
for 5 min at 2,000 x g in an International
model PR-2 refrigerated centrifuge using the lu’o. 253 head. The
organic phase was removed and the aqueous phase and interface
were re-extracted with an additional volume of I-butanol.
‘I’hc
organic phases were combined, washed with an equal volume of
H?O, concentrated to near dryness on a rotary evaporator at 25”,
and dissolved in 1 liter of CHCl,-CH,OH
(1: 1). The mannolipid was precipitated by addition of 5 volumes of acetone at O”,
and collected by centrifugation.
The crude lipid was dissolved
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Standard assay mixtures were incubated in 3-ml test tubes at
room temperature in the homogenizing
buffer containing 1 to 100
pM GDP-[‘*C]mannose
(25,000 to 200,000 cpm), 5 mM MnCl?,
5 mM M&12, and 0.6 to 3 mg of microsomal protein in a final volume of 100 ~1; larger incubation mixtures were scaled-up proporReactions were quenched by addition of 3 volumes
tionately.
of a solution containing 2 parts of I-butanol-1
part of 6 M pyridinium-acetate,
pH 4.2, and then vortexed.
The incubations
were then centrifuged for 3 to 5 min at maximum speed in the
No. 809 head of an International
model CL clinical centrifuge.
A distinct aqueous phase and proteinaceous interface is observed
from assay mixtures at low protein concentration,
but at higher
protein concentrations
the aqueous phase is occluded within a
proteinaceous
pellet.
The upper (organic) phase was removed
nearly quantitatively
with a 500.~1 syringe (Hamilton model No.
1750 N). A second extraction was performed with an additional
200 ~1 of I-butanol,
and the combined organic extracts were
washed with 500 ~1 of HZO. An aliquot of the organic phase n-as
dried at 70” in a scintillation
vial and counted in toluene-Triton
X-100 scintillation
fluid for estimation of mannolipid
formed.
The lipid-free protein pellet was dispersed and partially solubilized in 0.5 ml of 0.5 M NaOH by sonication for 10 s at minimum
power using the micro tip attachment of a Heat Syst.ems-Ultrasonics model W185 sonifier-cell disruptor.
Protein was reprecipitated by 235 ml of lOy0 trichloroacetic
acid and collected by
centrifugation.
This procedure was repeated, and the pellet was
finally washed with sonication in 2 ml of 80% ethanol.
The
protein pellet was dispersed in 100 ~1 of methanol, solubilized in
1 ml of Hyamine hydroxide 10X, and counted in 10 ml of toluene
scintillation fluid for determination
of mannose incorporated
into
protein.

of 99y0 CHaOH, 2 volumes of CHCla-acetic acid (3 :I), and 2
volumes of 99% CHSOH.
The mannolipid
was then eluted with
2 volumes of 99% CHSOH containing 0.2 M NH&,
concentrated
by flash evaporation,
dissolved in CHC13-CH80H
(2:1), and
washed by partitioning
against 0.2 volumes of I-120 as described
by Folch (24). This lipid was stored in CHC15 and ITas stable
to storage at -20” for at least 2 months.
Standard Incubation-Partially
purified [14C]mannolipid
was
added in CHCl, (50 to 100 ~1) to 50 ~1 of homogenizing
buffer
containing 1% Triton X-100, 10 m1\z MnCls, and 10 rnM I!lgCl~.
The CHCls phase was removed under a stream of dry nitrogen.
Aliquots of fresh or delipidated
microsomal protein suspensions
(1 to 3 mg of protein) were added with buffer to bring the final
volume to 100 ~1, and the mixture was incubated at roorn temperature, and quenched and processed as described above.
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Chromatography

and Electrophoresis

Descending paper chromatography
was carried out on Whatman xo. 1 paper, using the following
solvent systems: A,
isobutyric acid-concentrated
NHJOH-Hz0
(57 : 4 : 39) ; and B, lbutanol-pyridine-HtO
(9 :5 :4). Paper electrophoresis
was performed on Whatman No. 3MM paper using buffer systems: C,
1% sodium borate; D, 58 ml of 88% formic acid and 156 ml of
glacial acetic acid diluted with 1~20 to 2 liters (pH 1.85) ; and
E, 25.5 g of sodium bartital and 3.3 g of barbituric acid diluted
with Hz0 to 2 liters (pH 8.7). Unlabeled standard sugars and
their derivatives were located with aIkaline silver nitrate (28)
after treatment of the paper with 5 mM periodic acid in acetone.
Radioactivity
was located by scanning paper strips on a Packard
radiochromatogram
scanner, model 7201. Quantitation
of radioactivity
was accomplished
by cutting the paper strips into
l-cm pieces and counting them in a vial containing 20% aqueous
toluene-Triton
X-100 scintillation
fluid.
Thin layer chromatography
was performed on Silica Gel G in
solvent systems: F, CHC&CHaOH-Hz0
(12 :6 : 1) ; G, CHCl,CI-130H-HO&H20
(25 : 15 :4 :2) ; and II, CHC1&H30H3-concentrated NH40H (75 :25:4) ; and on alumina in solvent system
J, CHCIZ-ethanol-70
mM ammonium
acetate (18 :25:7) (29).
Lipids were located on chromatograms
by staining with either
iodine vapor or rhodamine 6G. Radioactivity
was located and
quantitated
by scraping l-cm cuts into scintillation
vials con-

MINUTES

1. Incorporation
of mannose into lipid and protein.
A
large incubation mixture (2 ml final volume) contained 4 UM GDPmannose (100,000 cpm) with 1.2 mg of protein per loo-pi aliquot.
Protein and lipid were measured from loo-p1 aliquots as described
under “Experiment,al
Procedure.”
Note the expansion of the
cpm lipid scale at 4000 cpm. This is done to permit comparison
of the relative kinetics and extent of loss of [14C]mannose from
the lipid fraction with the gain of [14C]mannose in the protein
fraction.
FIG.

taining 207, aqueous toluene-Triton
counting.

X-100

scintillation

fluid for

RESULTS

Synthesis and Characterization

of Mannolipid

Formation
of Mannolipid-In
preliminary
studies it was observed that incubation
of microsomal protein, isolated either
from the myeloma tumor or from murine or bovine liver, with
GDP-[‘%]mannose
resulted in an initial burst of mannose incorporation into a lipid fraction during the first 5 min, accompanied by a decreased rate and extent of mannose incorporation
in protein over a 2-hour period (Fig. I). Further studies revealed
that incorporation
into lipid is linear for about 5 min at 100 pM
GDP-mannose,
but reaches a maximum rapidly at lower substrate concentrations
because of substrate destruction presumably catalyzed by sugar nucleotide hydrolases in the microsomal
preparations;
the hydrolysis of GDP-mannose
results in a transient production
of a small amount of mannose-l-P,
but after 3
min incubation in the presence of 4 pM GDP-mannose
only mannose is detectable in the 80% ethanol extract of the incubation
mixture.
The microsomal preparations
are rich in both sugar
nucleotide hydrolase activity and phosphatase
activities, but
these enzymes were neither quantitated
nor further characterized.
The half-maximal
rate of lipid formation is attained at about
0.7 pM GDP-mannose
and requires 5 mM divalent cation for
maximal activity, but it exhibits no special preference for either
MnZ+ or Mg2+.
The reaction is greater than 95% inhibited by
2.5 mM EDTA.
Stimulation by Triton X-100 is variable; levels
up to 0.5y0 are not inhibitory and frequently result in up to l-fold
stimulation
of mannolipid
formation.
Additions of 2-mercaptoethanol, glutathione,
or KF had no significant, reproducible
effect on mannolipid
formation.
Reversibility ojMannolipid
Formation-Mannose
incorporation
into lipid reaches a maximum within 3 min at an initial concentration of 2 pM GDP-mannose
(Fig. 2). Addition of excess GDP
at 3 min results in a rapid loss of [%]mannose from the lipid fraction; the degree of displacement is dependent on the amount of
GDP added, and is completely inhibited by 10 mM EDTA (data
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in 1 liter of toluene-CHsOH
(1: l), and deacylated by mild alkaline methanolysis
(0.1 1\~KOH) for 5 min at room temperature
according to the method of White and Frerman (26) ; this procedure was repeated three times.
The lipid was dissolved in 1
liter of CHCls and applied to a 400-ml column of silicic acid.
The column was washed with 2 liters of CHC13, then the mannolipid was eluted with 2 liters of 99% CH,OH.
The eluant was
applied to a column of DEAE-cellulose
(4 x 22 cm) prepared
according to Rouser (23). The column was washed in succession
with 1 liter of 99% CH,OH, 1 liter of CHCla-acetic acid (3:1),
1 liter of 99% CHsOH, and eluted with a linear gradient of 0 to
0.2 sr XI-I&c (pH 4) in 99% CHBOH (27). The mannolipid was
eluted quantitatively
as a symmetrical peak of radioactivity
at
0.05 M NH4Ac.
The DEAE-cellulose
column was washed with
99% CHsOH to remove salt, and the pooled Folch-washed
lipid
was reapplied to the same column in CHCl&HsOH-concentrated NH,OH
(40 :20:1), and eluted with a linear gradient of
0 to 0.025 M NH4Ac (23). More than 95y0 of the radioactivity
was eluted as a single symmetrical peak at 0.005 M NH4Ac.
The
pooled lipid was concentrated and applied to a column of Sephades LH-20 (0.8 x 40 cm), and eluted with CHCI&HaOH
(1 :l),
again yielding a single symmetrical peak of radioactivity.
Preparative thin layer chromatography
was performed on Silica Gel
G in CI-ICI,-CH,OH-Hz0
(12:6: 1). Rhodamine
6G staining
revealed three components with RF values of 0.2, 0.4, and 1.0,
respectively.
All of the radioactivity
was found in the band at
RF 0.4. The mannolipid was eluted from the Silica Gel G with
CHC1&H30H-Hz0
(1 :l:O.l),
and saponified for 30 min at
70” under nitrogen in 60% aqueous KOH-absolute
ethanol (1:5,
v/v).
The resulting
nonradioactive
lipid was extracted by
addition of Hz0 and n-hexane.
Analytical
thin layer chromatography revealed a single component with an RF of 1.0 in
CHCls-CHZOI-I-H20
(12 :6: I). On development
of the chromatogram in a second dimension with CHCl,, about 90% of the
iodine staining material chromatographed
as a single component
with an RF 0.7.
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FIG. 2. Reversibility
of mannolipid
formation.
li:ach
poi&
represents
a separate
loo-p1 incubation
containing
I mg of microsomal protein
and 2 PM GDP-mannose
(50,000 cpm).
At 3 min,
10 ~1 of buffer were added to the controls,
and 10 ~1 of 1 mM GMP,
GDP,
or GDP-mannose
were added to other incubations.
not shown).
This loss is not observed
upon addition
of comparable
quant.ities
of either
G>IP
or unlabeled
GDP-mannose.
When
unlabeled
GDP-mannose
(4 pM) was used as substrate
for
an incubation
mixture,
then
followed
by a loo-fold
excess of

I

5

IO

MINUTES

FIG. 3. Specificity
of mannose
transfer
to endogenous
acceptor
lipid.
Standard
incubation
mixtures
(total
volume
SO0 ~1) contained
4 PM GDP-mannose
(100,000
cpm)
and 1 mM competing
nucleotide.
Aliquots
of 100 ~1 containing
0.6 mg of protein
were
withdrawn
for determination
of mannolipid.

[3H]GDP and quenched rapidly (10 s), [3H]GDP-mannose
could
be identified as a reaction product by chromatography
in Solvent
System A. These results are in agreement with those observed
in the pig liver system (8) and indicate that the mannolipid
is
formed by a reversible transfer of mannose to the acceptor lipid
with concomitant
formation of GDP as a product, as shown
below :
GDP-mannose
According

to this

+ acceptor
scheme

lipid

dilution

ti

mannolipid

of the

specific

+

GDP

activity

of the

GDl’-[14C]mannose
by addition of an excess of unlabeled GDPmannose (at 3 min in Fig. 2) should also cause a dilution of
radioactivity
in the lipid
by an exchange
reaction.
Richards
and Hemming (8) have demonstrated
this equilibrium
between
GDP-mannose
and mannolipid in the pig liver system, but, from
the results in Fig. 2, (cf. also Fig. 6), it is clear that the equilibration is not readily demonstrated
in the myeloma tumor system.
The

failure

of unlabeled

GDP-mannose

to dilute

the lipid

radio-

activity in these experiments may result from the rapid destruction of GDP in these incubations, such that the reverse reaction
in the proposed exchange reaction is prevented.
Spec$city of Mannose Transfer to Lipid--The
incorporation
of
[14C]mannose into the lipid appears to be relatively specific (Fig.
3) in that addition of large excesses of other unlabeled sugar
nucleotides does not significantly interfere with the total incorporation of mannose into lipid.
GDP-glucose is the only nucleotide
that inhibits incorporation
of mannose into lipid, but it is possible
that its degradation
products, GDP and GMP, are responsible
for this inhibition.
The small degree of stimulation
observed
with the other nucleotides could result from protection of the
GDP-mannose
from the microsomal hydrolases.
The insensitivity

with
in fact,

of the mannosyltransferase

results reported
transferred

from

to UDP-glucose

is at variance

for the pig liver system (8).
UDP-glucose

to a lipid

Glucose is,

in the myeloma

J
MINUTES

FIG. 4. Acid
and base hydrolysis
of crude
myeloma
tumor
mannolipid.
Acid hydrolysis
: 25,000 cpm of crude lipid dissolved
in 5 ml of CHCl&H,OH
(2:l)
containing
0.05 ml of 10 N HCl,
maintained
at 17” in a water
bath.
At specified
times 0.5.ml aliquots were neutralized
with 0.1 ml of 0.5 N NaOH,
vortexed,
and
centrifuged.
An aliquot
of the lower
(organic)
phase
n-as removed,
dried,
and counted
in toluene-Triton
X-100
scintillation
fluid.
Base hydrolysis:
25,000 cpm of crude lipid dissolved
in 4.5
ml of absolute
ethanol
and 0.5 ml of 1 N NaOH,
maintained
at
100” in boiling
water
bath.
Aliquots
of 0.5 ml were placed in ice,
neutralized
with 0.05 ml of 1 N HCl,
and partitioned
into two
phases by addition
of 0.8 ml of CHC13 and 0.15 ml of H?O.
The
lower phases were counted
as above.

tumor microsomes, as reported for the pig liver system, and this
lipid is indistinguishable
from the mamlolipid
on thin layer
chromatography
in Solvent
Systems
F, G, and II.
The reason
for the differences in the competitive
interaction between GDPmannose
and UDP-glucose
in the liver and myeloma
tumor
systems remains to be established.

Mild

acid or base hydrolysis

of crude lipid

extracts

(Fig. 4)
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CONTROL

f’uu$cation

of bovine Liver mannoLipi&

Fraction

p7m1es

extract..
Acetone precipitate.
Silicic acid eluate.
DEA@-eluate.
Sephadex LH-20 eluate..
Preparative
thin
layer
chromatography.
Brhmol

1.8

1.5
1.5

pmles

1.4 x 105

8 x 10”
x 104
1.2 x 103 800

8.6

1.0
0.8
0.3(1.1)c1

x

15
1.4

104

5.7

1 19
1

3.5(1.2)~

a See “Experimental
Procedure”
for details.
b From specific activity of CTI>P-[14C]mannose (1 &i per pmole).
c Redllcing sllgar estimated after acid hydrolysis by the method
of Park and Johnson (22).
organic phosphate in n-hesane using the Cary 14 recording
spectrophotometer)
was compared to the spectra of vitamin A
acetate and vitamin K (melladione)
at similar concentrations.
The absorption of both the mannolipid
and the free lipid (prepared by base hydrolysis) was llcgligible and featureless in the
300 to 400 nm range. There is no indication that the mannolipid
from bovine liver contains a conjugated carotenoid (vitamin A)
or ubiyuinone
(vitamin K) component in its structure, thus indicating that these polyisoprenoid
lipids are not a major form
of mannose-accepting
lipid in bovine liver in vitro.
Analysis of the lipid by mass spectrometry after alkaline hydrolysis indicates that the lipid is a polyisoprenoid
compound.
The mass spectrum, illustrated in Fig. 5, reveals a characteristic
pattern of triads of fragment ions separated by 68 mass units,
representing random cleavage between individual
isoprene units
in a chain. The prominent peak in each triad has a mass/charge
value of [(n x 68) + 21, i.e. 2 mass units greater than the equivalent ions for undecaprenyl lipids isolated from bacterial systems
(30, 31). The molecular ion was not visible in the mass spectrum
and, thus, the precise number of isoprene units in the lipid remains to be established.
However, on the basis of its spectral
characteristics,
it was concluded that the lipid was a dihydropolyisoprenol,
consisting of at least 18 isoprcne units, one of
which is saturated.
These results suggest that the lipid is a
form of dolichol (15), a C-100 a-saturated polyisoprenol,
which,
as dolichol monophosphate,
has been characterized as a glgcosyl
acceptor in liver microsomes by Lcloir (16, 32), and Hemming
(8), and their co-workers.
III addition,
the chemical and chromatographic
properties of the mannolipid
are comparable
to
those of synthetic dolichol-monophosphate-mannose
prepared according to Behrens, Leloir et al. (16, 32).
Role oj Mannolipid

in Glycosylation

of Protein

Incorporation
sf Xannose
into Mannolipid
and Protein-As
shown in Figs. 1 and 2 the incorporation
of mannose from GDP[14C]mannose into mannolipid
reached a plateau after al)proximately 5 min of incubation in the presence of less than 10 pM
GDP-mannosc.
The cessat,ion of mannolipid formation could be
attributed
to the total destruction of GDP-mannose
in the incubation mixture within the first 5 min. As illustrated in Fig. 1,
however, incorporation
of mannose into protein continued for at
least 2 hours, concomitant with a decrease in mannolipid.
During the period from 5 to 120 min, the radioactivity
in protein
increased by approximately
500 cpm, while the decrease in mannolipid during the same period was approximately
1000 cpm.
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resulted in quantitative
rrlease of radioactivity
into the aqueous
phase following Folch partitioning
against I&O (24). On treatment of’ the [‘4C]Ixalliiose-labeled
lipid with 0.01 s IICl for 2 min
at 100” ill 50% I-propanol,
the radioactivity
is recovered quantitatively in the aqueous phase as [‘4C]mannose (identified
by
chromatography
in Solvent System U). No other radioactive
compoul~cl was detectable.
In 0.1 x HCl in CHCl,CH,OH
(2:l) at 17” the mannolipid
has a half-life of 15 min, and the
products in the aqueous phase were identified as mamlose
and
methyl-mannoside
(chromatography
in Solvent System A and
electrophoresis
in 1% sodium borate).
In 0.1 s NaOH in 90%
ethanol at IOO”, the mamiolipid
has a half-life of 1.5 min, and
the product in the aqueous phase was identified as rnannose-1-I’
(chromatography
in Solvent System A and elect’rophoresis in 1 y0
sodium borate).
Hased on the kinetics of hydrolysis of the lipid
in both acid and base and the nature of the water-soluble
products, it was concluded that the mamlosc was linked by a glycoside
bond to the lipid moiety through a phosphate or pyrophosphatc
bond.
Ckaracferization 01 Xannolipid-The
[14C]maniwlil)ids
formed
with either the myeloma tumor or bovine liver systems were indistinguishable
and both appeared to be single species by several
criteria.
(n) *-1 single band of radioactivity
was located on
analytical thin layer chromatography
on Silica Gel G in Solvent
Systems F (RF = 0.6), G (RF = 0.95), and H (RF = 0.35), and
on alumina in Solvent System J (RF = 0.2). (b) During preparativc isolation of the lipid (see “Experimental
Procedure”)
a single
peak of radioactivity
\vas obtained from a column of DEAEcellulose cluted xvith a gradient of 0 to 0.2 M NH&c,
111-I4, in
99% CI-1,01-I (elution at 0.05 M salt), or a gradient of 0 to 0.025 M
NHIA\c in CI-IC113-CI180H-colIcclltratcd
NII,OT-I (40 : 10 : 1) (elution at 0.005 M salt).
(c) A single peak of radioactivity
was
obtained on elution from Sephades LH-20 and LI-I-60 in three
diffcrcwt solvents: C’HC13, 99 y0 CI1,01-I, and CHCl&HBOH
(1 :l).
(d) The kinetics and estent of acid and base hydrolysis
of the malulolipid
in crude extracts were consistent with the
esistenw of a single species of lipid.
In order to obtain sufficient quantity for structural studies,
tile rnalmolipid
was purified from bovine liver microsomes by
standard
fractionation
tcchniqucs
(see “Esl~crimental
Proccdure”), and the phospl~orus to sugar ratio in the lipid was used
as an intlt,.\; of purification
(Table
I). The final product,
20,000-fold purified over the crude estract, exhibited an organic
phosl~horus to acid-labile
reducing sugar ratio of 1.2. This
product uxs hon~ogrneous in terms of the distribution
of radioactivity and iodine staining on thin layer chromatography
on
Silica Gel G in Solvent S1.st ems F, G, and I-I. The discrepancy
bctwwl
the quantity of mannose in the lipid determined
by
specific radioactivity
of the GDP[Wlmannose
and that determined by reducing sugar assay following mild acid hydrolysis
probably- reflects the prescncc of a low level of endogenous mannolipid ilr thr microsomal preparation.
In the experiment outlined in ‘1’ablr I, a 33ci, loss of lipid occurred in the 1)urification
n-hen the lipid was csposc~l to acidic conditions during concentration of’ fractions from the first I>EAE-cellulose
column.
This
n-as a handling error, and in subsequent isolations, the over-all
recovery at t’hc stage prior to thin layer chromatography
was
improwd
to better than 90(;;,. Recovery of the radioactive lipid
from the single radioactive band obtained on thin layer chromatograms rarely csccedrd 60yc; this loss resulted frorn both irrcwrsiblc adsorption of the lipid to silica gel, and partial degradation of a fraction of the lipid to water-soluble
forms.
‘1’h(l ultraviolet
spectrum of the purified mannolipid
(0.1 mM
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Thus, these results suggested that the mallnose-contaillirlg
lipid
was serving as a precursor to mannose residues incorporated
into
the protein fraction.
In these experiments, mannolipid
formation accounted for 5
to 10% of added substrate, and 0.2 to 1 y0 of the [14C]mannose was
In general, the amount of
recovered in the protein fraction.
[14C]mannose incorporated
into protein after 2 hours of incubation was directly proportional
to the amount of mannolipid originally formed in the incubation mixture.
In Figs. 6 and 7 this
dependency of protein mannosylation
on lipid formation is also
observed. Loss of [14C]mannose from the mannolipid,
however, is
generally 2- to 3-fold in excess of the amount required fol mallIt is apparent that some of the mannonosylation of protein.
lipid is undergoing
degradation
to produce free mannose or
mamiose l-phosphate,
but another more complex product, in
addition to protein, is also being formed from the mannolipid;
this is discussed in more detail in the text discussion of Fig. 8.
Pulse-chase Kinetics-When
the GDP-[Slmannose
is chased
by an excess of nonradioactive
substrate at times prior to the
cessation in mannolipid
formation (less than 3 min), the subsequent incorporation
of radioactivity
into lipid and protein is
affected differently.
As illustrated
in Fig. 6, addition of a IOOfold excess of GDl-‘-mannose at 30 s results in an abrupt cessation
in mannose incorporation
into the lipid fraction, with an eventual
resumption of incorporation
at about >iooth the original rate.
Despite the effective chase in the mannolipid-forming
reaction,
however, incorporation
of mannose into protein persists following
the chase and ultimately
reaches a value proportional
to the
amount of mannose incorporated
into the mannolipid during the
30-s pulse, i.e. total incorporation
into protein at 60 min is about
8% of mannolipid
formed in each incubation
mixture.
From
2 We are indebted

to Dr. Iain Campbell

etry Facility,
University
spectral
analyses.

of Pittsburgh

of the Mass Spectromfor

conducting

the

mass
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FIG.
5. Mass spectrum
of bovine
liver mannoliuid.
Purified mannolipid (0.5 ELM- organic phosphorus)
was saponified as described under
“Experimental
Procedure,”
and analyzed by mass spectrometry
on an
LKB type 9000 mass spectrometer at
70 e.v. ionization energy, using a direct probe at 25OO.2

FIG.

and

6. Pulse-chase kinetics of mannose incorporation

protein.

Two

separate

incubations

of

1.0 and

into lipid
1.3 ml,

re-

spectively, contained 4 PM GDP-mannose
(100,000 cpm) with 1.2
mg of protein per loo-p1 aliquot.
To the first incubation 100 ~1
of 10 rnM GDP-mannose were added as a chase at 30 s, and aliquots
were
trol)

withdrawn
had been

starting
at 1 min.
diluted
equivalently

The second incnbation
with buffer
at zero time.

(con-

these results, GDP-mannose
appears to be the direct precursor
for mannose incorporation
into the mannolipid,
but not into the
protein
fraction.
The results are consistent with the previous
evidence (Fig. 1) that the mannolipid may serve as an intermediate in the transfer of mannose from GDl’-mannose
to protein.
Effect of EDTA on Incorporation
OJ”Xannose
into Lipid and
Protei?L-Addition
of 50 mar EDTA to an incubation at 5 min,
after mannolipid
formation has reached a maximum, has no significant effect either on the subsequent kinetics and cstcnt of
mannose incorporation
into protein or on the rate of disappcar-
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7. Effect
of EDTA
on incorporation
of mannose
into lipid
and protein.
All incubations
were
conducted
at 4 FM GDPmannose (100,000 cpm), and contained 1.2 mg of protein per 100.~1
aliquot.
Aliquots
of 0.5 M sodium
EDTA,
pH 7.0, were added at
-5 min (preincubation)
or at +30 s or +5 min respectively;
GDP-mannose
was added at zero time.
Final
EDTA
concentration was 50 mivr.
FIG.
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FIG.
8. Direct
transfer
of mannose
from mannolipid
to protein.
A I-ml incubation
mixture
contained
20 mg of delipidated
microsomes and 40,000 cpm of partially
purified
mannolipid.
Aliquots
(100 ~1) were quenched
with 300 ~1 of butanol-pyridinium
acetate
then diluted
with 200 ~1 of HZO, and centrifuged.
Distinct
aqueous and organic phaseswere
collected
separately;
two additional
extractionswere
performed
with 300~1 of butanol-pyridinium
acetate
and 200 ~1 of HeO, and the aqueous
and organic
extracts
were
pooled
and counted.
The
protein
fraction
was washed
and
counted
as described
under
“Experimental
Procedure.”

Downloaded from http://www.jbc.org/ at USC SCHOOL OF MEDICINE on September 30, 2014

z
w
k
I

500

ante of mannose from the lipid fraction (Fig. 7, upper two curves
of each frame).
Preincubation
with EDTB,
or addition of
EDTA immediately prior to addition of GDP-mannose,
however,
result’s in nearly complete inhibition
of mannose incorporation
into bot’h lipid and protein (Fig. 7, lowest curve of each frame).
If EDTA is added at intervals up to 5 min (30 s in Fig. 7), incorporation of mannose into lipid ceases immediately while mannose incorporation
into protein continues to an extent approximately proportional
to the amount of mannolipid
formed prior
to addition of EDTA.
Even
in the mixture
preincubated
with
EDTA, the amount of [‘%]mannose incorporated
int’o protein is
approximately
5 to 10°yO of the mannolipid
formed.
Thus, by the use of EDTA to &elate divalent cations, it is
possible to show that, of the two mannosyltransferase
reactions,
only the transfer to lipid is dependent on Mn2f or Mg2+. Nevertheless, the extent of mannose incorporation
into protein is indirectly sensitive to EDTA
and is controlled
by the extent
to which
mannose is incorporated
into lipid.
These observations
are
similar to those of Scher and Lennarz (33) on mannan synthesis
in Micrococcus lysodiekticus, and provide further indirect evidence
that the mannolipid is an intermediate
in the transfer of mannose
from GDP-mannose
to protein.
Direct Transfer of Mannose from Mannolipid
to Protein-All
attempts to demonstrate the transfer of mannose from exogenously supplied, crude mannolipid
preparations
to endogenous
microsomal protein were unsuccessful.
However, delipidation
of the microsomal preparation by treatment with organic solvents
and partial purification
of the [14C]mannolipid used as substrate
provided a system that permitted the direct utilization
of the
mannolipid
as a mannosyl donor in the glycosylation of endogenous microsomal protein.
It was later shown that delipidation
of the microsomes was not necessary, but that the most critical
factor was the use of purified [r4C]mannolipid as substrate.
This
purification
scheme (see “Experimental
Procedure”)
degrades
glycerophospholipids
by alkaline methanolysis,
and uses batch
elution from DEAE-cellulose
with CHCL-acetic
acid (3: 1) to
remove neutral lipids, fatty acids, and bile salts (23). The mannolipid is then eluted with 9997, CH30H containing 0.2 M NH4Ac.
The utilization
of the purified [14C]mannolipid as substrate for
the transfer of mannose residues to protein is illustrated
in Fig.
8. In this incubation mixture approximately
15% of the [‘“Clmannose added as [14C]mannolipid
was transferred to protein.
A larger proportion
of the radioactivity
was recovered in the
aqueous phase. When the material in the aqueous phase was
collected from a second incubation mixture quenched at 60 min
and chromatographed
on a column of Rio-Gel P-2 in H20, 50%
of the radioactivity
eluted as a sharp peak at the exclusion volume of the column (exclusion mol wt - 1800). The remainder
eluted as a second sharp peak at the retention volume, and was
identified as mannose by electrophoresis
in 1 y0 sodium borate.
When the material at the exclusion volume of the P-2 column
was rechromatographed
on Sephadex G-50 in 0.15 M NaCl, it
was eluted as a single peak of radioactivity
with an apparent
molecular weight of 2200 (estimated from data in Reference 34).
This material migrated toward the anode upon electrophoresis
in Buffer D at pH 1.85, but treatment with alkaline phosphatase
converted it to a neutral compound, indicating that it was not
a peptide.
The composition,
source, and function of this low
molecular weight compound containing mannose and phosphate
are currently under study.
The extent of transfer of mannose from mannolipid
to protein
is dependent on several factors.
[14C]Mannolipid
in the crude
lipid extract is totally inactive as a glycosyl donor, probably
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!I. I<ffect of protein

15,000

20,000

23000

LIPID

(A) and lipid

(B) concentration

on

transfer
of mannose
from
mannolipid
to protein.
Standard
300-J
incubation
mixtures
contained
increasing
aliauots
of delipidated
protein
(A) or partially
purified
marm&pid*(B).
In A,
incubations
contained
10,000 cpm of lipid.
In B, incubations
contained
10 mg of prot.ein.
Separate
zero time blanks
were run
for each incubation.
The yield of [lVZ]mannose-labeled
protein
was measured
at 45 min.

or mannolipid.
While there is evidence that yeast mannans
are synthesized from GDP-mannose
by way of a mannolipid
intermediate
(38, 39), addition of yeast mannan to incubation
mixtures had no effect on the tumor system.
The fact that addition of greater amounts of exogenous lipid
to an incubation results in an increased yield of [‘4C]mannosclabeled protein (Fig. 9B) probably indicates increased activity
of the labile transferase at increasing, but subsaturating,
levels
of the mannolipid
substrate.
These observations are consistent
with similar experiments using fresh microsomes with GDPmannose as substrate where the extent of mannose incorporation
into protein is also linearly dependent on both the l)rotcin concentration
(data not shown) and the amount of mannolipid
generated endogenously from GDP-mannose
(Figs. 6 and 7)
Effect oj Organic Solvent Extraction of .Microsomes-Butanol
or
acetone (31) extraction of microsomes caauses a 40 to 607; decrease in the amount of [14C]mannolipid
formed from GDPmannose per mg of protein in an incubation mixture.
There is
also a proportional
decrease in the amount of mannose trailsferred from GDP-mannose to protein.
The activities for transfei
of mannose to lipid and protein are not sensitive to the organic
solvent extractions,
however, since both activities can bc restored to their original levels by supplementing
the incubation
mixtures with aliquots of the organic solvent extract.
The
restoration of activity is dependent on an acidic lipid fraction
(based on DEAE-cellulose
chromatography)
which is stable to
mild alkaline methanolysis.
The active lipid is presumably the
mannose acceptor lipid, dihydropolyisoprenol
monophosphate.
The simultaneous
stimulation
of mannose transfer from GDPmannose to both lipid and protein is consistent with its proposed
role as a glycosyl carrier lipid.
Richards and Hemming
(8)
have also reported the stimulatory
effect of polyisoprenol
phosphates on transfer of mannosc from GDP-mannose
to both lipid
and protein in liver microsomal preparations.
Relative Eficiency OJ”Endogenous and Exogenous
Mannolipid
as Jlannose Donor to Protein-The
observation that crudr microsomes could transfer mannose from mannolipid
to protein provided a means to test quantitatively
the precursor-product
relationship between mannolipid
and mannosylated protein.
Thus,
regardless of whether GDP-[‘*Cl mannose is used as the original
substrate to generate [W]mannolipid
in s&l, or a similar amount
of [14C]mannolipid is supplied esogcnously, the same amount of
[W]mannose
should be incorporated
into protein.
The results
shown in Table II establish that crude microsomes utilize tither
endogenously
generated (from GDP-mannose)
or esogrnously
supplied mannolipid with equal efficiency for transfer of mannose
to protein.
In both Experiments
A and I{ the percentage of
transfer of mannose from endogenously generated mannolipid
to protein is comparable to the percent.age of transfer from esogenously supplied lipid.
The presence of the large excrssc~ of
GDP-mannose
(200,000 to 360,000 epm) in the experiments
generating
endogenous mai~i~olipicl results in no mannosc illcorporation into protein beyond that which can be accounted fol
by the lipid alone. Thus, the role of GDP-mannosc
as a direct
and immediate donor of mannose residues to protein npl)cars to
be insignificant
in the mycloma microsomal system. Similar
results were observed using mouse liver microsomes.
Xannolipid
as Direct Donor OJ SIannose to ProteirL-Ricshards
and Hemming (8) have reported that incubation
of [14C]mannolipid with pig liver microsomcs results in the formation of
GDP-[Wlmannosc,
presumably by reaction of the mannolipid
with
endogenous GDP in the microsomal prcparatiom..
‘l’llLlS,
it is conceivable that the mannolipid
is functioning
as a stable
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because of contamination
by a large excess of other lipids and
their degradation
products.
The partial purification
obtained
by alkaline mcthanolysis and DE;1E-cellulose
chromatography
yields an active preparation,
and further purification
by thin
layer chromatography
after the DEAE-cellulose
step results in
only a slight increase in activity.
The advantage of the additional purification
step, however, is offset by the poor recovery
of mannolipid
from thin layer plates. Delipidation
of the microsomal protein does not alter the amount of mannose transferred from mannolipid
to protein during an incubation, but the
transferase activity is more stable to storage following delipidation. It is possible that the transferase is sensitive to free fatty
acids and lysophospholipids
released gradually by phospholipases
in the microsomes.
Since the delipidation
procedure removes
greater than 90% of the lipid phosphorus,
the formation
of
these inhibitors would be decreased.
The extent of transfer of mannosc from mannolipid
to protein
is directly proportional
to both protein and lipid concentration
(Fig. 9). The increasing extent of mannolipid
utilization
for
transfer to protein with increasing protein concentration
(Fig.
9A) is expected in a reaction dependent on endogenous acceptor.
The addition of several different proteins (e.g. bovine serum
albumin, ovalbumin, thgroglobulin,
and ribonuclease) to incubations results in a nonspecific stimulation
of incorporation
of
mannose into endogenous protein acceptors by the tumor microsomes. Despite the fact that ovalbumin has terminal mannose
and acetylglucosamine
residues (35), and thyroglobulin
(36) and
ribonuclease
(37) have terminal mannosc residues, there is no
indication,
by gel chromatography
of the mannose-containing
protein products of an incubation,
that an>- of these proteins
serves as an exogenous mannose acceptor from GDP-mannose

5702
reservoir of activated mannose residues, gradually generating
GDP-mannose
to serve as the actual donor of mannose to protein during the incubation.
The results in Table III describe a
direct experiment to verify the role of mannolipid
as the immediate donor of mannose to protein.
Thus, in the presence of 50 mM EDTA, transfer of mannose
from GDP-mannose
to both lipid and protein is greatly inhibited
(Table III, compare first two lines of each experiment).
Less
than 0.050/, of the mannose is transferred to protein in either
experiment in the presence of EDTA.
Under the same conditions, however, exogenously added mannolipid
functions as a
relatively efficient donor of mannose to protein (Table III, last
line of each experiment).
About 2% of the mannose radioTABLE

II

Each incubation
contained
5 mM MgClz,
5 mM MnC12,
0.5yo
Triton
X-100,
and 3 mg of protein
in a total
volume
of 200 ~1.
Experiments
A and B were performed using separate preparations
of both protein
and lipid.
The mannolipid
counts
per min value
in parentheses
(incubations
using
GDP-mannose
as substrate)
is the amount
of mannolipid
formed
from
the GDP-mannose
at
5 min (plateau).

-

Substrate

Percentage
of
of lipid
to protein

t1ransfer

-

Experiment

C:DP-mannose
-

Mannolipid

--

cpm

A
B

200,000

@3,0@3)

360,000

28,000
(50,800)
27,000

2,876
3,247
2,799
1,208

10
12
5.5
4.5

-

TARLE

III

Effect of EDTA on mannose transfer to protein from
GDP-mannose and mannolipid
Each incubation
mixture
contained
0.5% Triton
X-100
and 3
mg of protein
in a final volume
of 200 pl.
Either
5 mM MgCls
and
5 mM MnCls
(MS+), or 50 mM sodium
EDTA,
pH 7.4 were added,
as indicated.
Experiments
A and B were performed
with different protein
preparations.
Reactions
were quenched
at 45 min
for determination
of mannose
incorporated
into protein.
The
mannolipid
counts
per min value
in parentheses
(incubations
with
GDP-mannose
as substrate)
is the amount
of mannolipid
determined
at the 45-min
time point.
Percentage
of transfer
to
protein
is based on amount
of added substrate;
values
in parentheses are based on amount
of mannolipid
generated
endogenously
from GDP-mannose.

-

Substrate
Experiment

M*
GDPmannose

Mannolipid

360,000
360,000

(32,700)

12DTA

Product
protein

Percentage
of
transfer
from
original
substrate
to
protein

CM
-

Gv80)

+
-

45,000
45,000

+

-

260,000
360,000

+
+
-

1,214
152
1,930
1,034

0.3
0.04
4.3
2.2

640
25
587
362

0.17
0.01
2.9
1.8

Characterization

of Protein

Products

Gel Chromatography-Since
fresh microsomes could use either
GDP-mannose
or mannolipid
for mannose transfer to protein,
the protein products formed from the two substrates could be
compared.
The radioactivity
profiles of the sodium dodecyl
sulfate-solubilized
protein products on Sephadex G-150 (Fig.
10A) indicate that both GDP-mannose and mannolipid are transferring mannose to the same endogenous protein acceptor(s)
in the myeloma tumor microsomes.
In addition, the majority
of the radioactivity
elutes in a peak which has the same elution
volume as authentic K-46, the predominant
species of glycoprotein in the MOPC-46B
cell. This elution pattern is different
from that obtained with microsomes of the host mouse liver (Fig.
10B) which synthesizes a whole spectrum of proteins for secretion. Even in the liver, however, there is an essential identity
between the radioactivity
profiles of protein labeled from either
GDP-mannose or mannolipid.
Proteolytic
Digestion-Confirmation
that mannose-labeled
product which was precipitable
by organic solvent (butanolpyridinium
acetate), 10% trichloroacetic
acid and 80% ethanol,
was, in fact, a glycoprotein
was obtained by demonstrating
its
conversion to low molecular weight material upon incubation
with proteolytic
enzymes (Fig. IOC). Control
incubations
without proteolytic enzymes showed less than 5% conversion to
low molecular weight products, while proteolysis normally resulted in 50 to 100% conversion with an average value of about
70%.
Proteolysis was performed in 5 M urea, and both Pronase
and subtilisin were required for efficient digestion.
The protein
products had been thoroughly
denatured
and aggregated by
precipitation
and extraction with organic solvent, trichloroacetic
acid, and ethanol, and were not readily digestible under milder
conditions of proteolysis.
The undenatured mannose-containing
protein in the incubation mixtures, however, was greater than
80% digestible by Pronase, subtilisin, trypsin, or pepsin but not
by hyaluronidase
or P-amylase, as determined by the decrease
in butanol-pyridinium
acetate and trichloroacetic
acid-precipitable radioactivity
at the end of 4 hours.
The low molecular weight products of the proteolytic digestion
were subjected to electrophoresis
under acidic (Buffer D) and
basic (Buffer E) conditions
(Fig. ll), and were shown to be
zwitterionic,
behaving as cations at pH 1.9 and anions at pH 8.7,
consistent with their characterization
as glycopeptides.
Within
the limits of resolution of the electrophoresis, the glycopeptides
from GDP-mannose and mannolipid behave identically.
Follow-
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Relative eficiency
of endogenously
formed
versus exogenously
added mannolipid as substrate for transfer of
mannose
to protein

activity is transferred from mannolipid
to protein, and about
80% is recovered unchanged from the incubation.
Even if all
of the exogenously added mannolipid
substrate were converted
to GDP-mannose
in these incubations,
this amount of GDPmannose would be inadequate to account for the protein product
because of the low efficiency (0.05%) of transfer from GDPmannose in the presence of EDTA.
Thus, the mannolipid must
be serving as the direct donor of mannose residues to protein and
as a true intermediate
in the mannosylation
of glycoprotein by
GDP-mannose.
A 40 to 50% inhibition
of mannose transfer from lipid to protein is observed in the presence of EDTA (Table III, compare
last two lines of each experiment).
The reason for the effect is
not clear, but it may result from differential
solubility
or an
altered state of the mannolipid
in incubation
mixtures in the
absence of divalent cation.
This effect of EDTA is not observed
in the absence of Triton X-100 (cf. Fig. 7) where the lipid is
presumably firmly fixed in the microsomal membrane structure.

A. MOUSE
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TUMOR

A

PROTEIN

GDP-MAN
HAc-HCOOH
pH 19

,x-x.

“,\

ri

?
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400
200

8.
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0
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Barbital.
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0
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400

PROTEOLYTIC
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FRACTION
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NUMBER

FIG. 10. Sephadex
G-150 profiles
of sodium dodecyl
sulfate-solubilked
protein
from incubations
using GDP-mannose
(X- - -X)
or mannolipid
(O--O)
substrates.
Protein
recovered
from
incltbations
was solubilixed
in 2.5y0 sodium
dodecyl
sulfate,
1%
mercaptoethanol,
0.1 M EDTA,
0.05 M sodium
phosphate,
pH 8.0,
applied
to a cohlmn
(1 X 40 cm) of Sephadex
G-150,
and eluted
n-ith the same buffer
containing
1% sodium
dodecyl
sulfate.
A,
mannose-containing
protein
from
incubations
with mouse
myeloma microsomes.
The position
of [3H]leucine-labeled
K-46, prepared
according
to Melchers
et al. (40), is shown
at one-tenth
scale.
H, mannose-containing
protein
from
incubations
with
mouse liver.
C’, tumor
protein
after proteolysis
by Pronase
and
subtilisin
(see “P:xperimental
Procedure”).
Glycopeptides
were
pooled
(Fractions
35 to 47) for electrophoresis
shown
in Fig. 11.

FIG. 11. Electrophoresis
of
glycopeptides.
The
mannose
containing
protein
from
incubations
of myeloma
trlmor
microsomes with
either
GDP-mannose
or mannolipid
were digested
with Pronase
and subtilisin
and were processed
as described
lmder
“Experimental
Procedure.”
Electrophoresis
was performed
for
2 hours
at, 2500 volts.
An unlabeled
mannose
standard
was included
in each sample
to measure
the migration
of neutral
compolmds
in the electroendosmotic
flow of buffer.

GDP-mannose
had been completely degraded in the incubation
mixture (Fig. l), incorporation
of mannose into protein continued concomitant
with a loss of radioactivity
from the lipid
fraction.
(b) When GDI’~[14C]mannosc was chased with a large
excess of nonradioactive
substrate, incorporation
of [Wlmannose
into protein continued normally
(Fig. 6) to an extent proportional to the amount of [14C]mannolipid
formed prior to t,hc
chase. (c) As shown in Fig. 7, EDTA inhibits transfer of mannose

to both

Final yields were 12,900 cpm of peptide from 17,850 cpm of protein

addition

from
from

cessation
continued

GDP-manuose
(73y0 recovery),
and
11,700 cpm of protein
from mannolipid

ing acid
was shown

hydrolysis
that

of separate preparations

all of the radioactivit’y

a rnannose standard
13.

7000 cpm of peptide
(60% recovery).

of glycoprotein

co-chromxtographed

on paper chromatography

it
with

in Solvent System

The

results

ol’ the

present

study

clearly

establish

that

a dihy-

of mannose
rrsidues
to protein.
It is clear that
not forming
GDP-mannose
i?z situ to serve as the
silw,
in the presence of EDTA,
GDP-mannose
the glycosylatiorr
of protein.
Three
independent

approache?
the

role

using GDP-[W]mannose

of the

mannolipid

as initial

as an intermediate.

mannolipid
is
glycosyl
donor

is ineffective

in

experimental

substrate
(a)

confirm

When

the

and

protein

when

added

at zero

time,

while

the incubation resulted only in a
formation.
Iircorporalion
into protein

of mamiolipid
aft,erwards

to au extent

proportional

to the amount

of

mannolipid
formed prior to addition of EDTA.
In experiments with the microsomal preparation from mycloma
tumors, it appears that the rnannolipid is an essential intermediat,c in mannose transfer to protein.
When microsomes were
incubated with either GDP-mannosc
or mannolipid
as substrate,
the gel fikration

dropolyisoprenol
phosphate functions as a glycosyl carrier lipid
in mammalian systems, mediating tExe transfer of mannose from
GDP~mannose to protekn.
The experiments
described
in Table
I II establish that the mannolipid
can function as a direct donor

lipid

at later times during

profiles

of the protein

products

are qualitatively

similar (Fig. 10). Electrophorctic
comparison of the peptides
produced by proteolysis of the protein products from either substrate, GDP-mannose
or mannolipid
(Fig. II), also supports the
contention
that
both
substrates
arc glycosylating
the same or
similar

proteins.

Moreover,

it is clear

from

II that the amount of mannose transferred
tively
proportional
regardless
of whether

to the amount
the mannolipid

the

results

in Table

to protein is quantita-

of mannolipid
was generated

available,
endogenously

from GDP-mannose
or added esogenously.
The mannosylated protein formed in tumor microsomes from
either GDP-mannose
or mannolipid
fractionates on Sephades
G-150 in sodium dodecyl sulfate in essentially the same relative
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position as authentic K-46 (Fig. lOA).
Further studies are in
progress to determine whether the acceptor protein is, in fact,
related to the sgnthcsis of K-46, the major natural glycoprotein
product of the myeloma tumor in VT&J. It can bc seen, hoIT-ever,
that the mannosylated
proteins formed in mouse liver microsomes are different from those observed in the tumor system,
suggesting that there is a characteristic class of protrins gl\-cosylated in each cell type.
Only a single species of polyisoprenoid
mannolipid
II-as detected in bovine and mouse liver and in the mouse myeloma
tumor.
The ultraviolct
and visible spectra of the purified mannolipid provided no evidence of a conjugated carotenoid (vitamin A), chromanr (vitamin E), or ubiquillonc
(vitamin K) structure, nor did the mass spectrum of the lipid at probe temperatures
below 250” revcal fragmentation
patterns attributable
to these
polyisoprenoid
vitamins.
These results do not exclude the
possibilities that: (a) vitamiu A (41-43)) E, or K (44) derivatives
may serve as mannose acceptors in vitro; (b) they may function as
glycosyl carrier lipids in other cell Qpes; or (c) these vitamins
ma)- be converted in vivo to a lipid which serves as a mannose
acceptor.
It appears, liowewr,
that the endogenous glycosyl
carrier lipid participating
in transfer of mannosc to protein in the
liver and myeloma tumor is a long chain dihydropolyisoprellol
phosphate.
It is not yet clear whether the same lipid or distinct
members of a family of isoprcnoid lipids function as carriers for
different sugars, but there is strong evidence indicating that both
glucose (16, 32, 45) and A-acetylglucosamine
(46-48) are transferred to protein through glycolipid intermediates.
In bacterial systems the underaprenyl
lipids function in the
cell enr-elope as glycosyl carrier lipids, intermediate
in the
biosynthesis and polymerization
of con~l&x carbohydrate-containing macromolecules
(13, 14, 27, 30, 31, 33). Thilc there is
no direct evidence, a similar mechanism may also be operative
in mammalian systems for the synthesis of the core region of the
oligosaccharide
side chain of plasma glycoproteins.
1101x-ever,
in the myeloma system we were unable to dctcct any species
of lipid which contained more than a single mannose residue or
both mannose and A’-acetylglucosamine
residues, as might be
espwted if the core oligosaccharide
were first constructed on a
lipid backbone, prior to transfer to protein.
But the low molecular weight (-2200)
compound containing mannose and phosphate, a major product formed when mannolipid
is incubated
with tumor microsomcs, may be a degradation product of such a
lipid.
If this is the case, then the polyisoprenoid
mannolipid
dcscribcd in this study may not be the only glycolipid illtermediate in\-olved in the transfer of mannose from GDP-mannose
to
protein.

